ID   FBCD1_HUMAN             Reviewed;         461 AA.
AC   Q8N539; A3KFK0; Q6UXK6; Q96SJ7;
DT   10-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   10-JUL-2007, sequence version 2.
DT   03-AUG-2022, entry version 137.
DE   RecName: Full=Fibrinogen C domain-containing protein 1;
GN   Name=FIBCD1; ORFNames=UNQ701/PRO1346;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19710473; DOI=10.4049/jimmunol.0901526;
RA   Schlosser A., Thomsen T., Moeller J.B., Nielsen O., Tornoee I.,
RA   Mollenhauer J., Moestrup S.K., Holmskov U.;
RT   "Characterization of FIBCD1 as an acetyl group-binding receptor that binds
RT   chitin.";
RL   J. Immunol. 183:3800-3809(2009).
RN   [6]
RP   FUNCTION, SUBUNIT, IDENTIFICATION BY MASS SPECTROMETRY, AND MUTAGENESIS OF
RP   ASP-393; ASP-395; TYR-405; HIS-415; TYR-431; ALA-432 AND TRP-443.
RX   PubMed=19892701; DOI=10.1074/jbc.m109.061523;
RA   Thomsen T., Moeller J.B., Schlosser A., Sorensen G.L., Moestrup S.K.,
RA   Palaniyar N., Wallis R., Mollenhauer J., Holmskov U.;
RT   "The recognition unit of FIBCD1 organizes into a noncovalently linked
RT   tetrameric structure and uses a hydrophobic funnel (S1) for acetyl group
RT   recognition.";
RL   J. Biol. Chem. 285:1229-1238(2010).
CC   -!- FUNCTION: Acetyl group-binding receptor which shows a high-affinity and
CC       calcium-dependent binding to acetylated structures such as chitin, some
CC       N-acetylated carbohydrates, and amino acids, but not to their non-
CC       acetylated counterparts. Can facilitate the endocytosis of acetylated
CC       components. {ECO:0000269|PubMed:19710473, ECO:0000269|PubMed:19892701}.
CC   -!- SUBUNIT: Homotetramer; disulfide-linked. {ECO:0000269|PubMed:19710473,
CC       ECO:0000269|PubMed:19892701}.
CC   -!- INTERACTION:
CC       Q8N539; P21145: MAL; NbExp=6; IntAct=EBI-10200808, EBI-3932027;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type II
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8N539-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N539-2; Sequence=VSP_026618, VSP_026619, VSP_026620;
CC   -!- TISSUE SPECIFICITY: Expressed in the small and large intestinal
CC       epithelial cells with a highly polarized localization to the apical
CC       surface corresponding to the brush border and in the ducts of the
CC       salivary gland. {ECO:0000269|PubMed:19710473}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY358311; AAQ88678.1; -; mRNA.
DR   EMBL; AK027716; BAB55319.1; -; mRNA.
DR   EMBL; AL161733; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032953; AAH32953.1; -; mRNA.
DR   CCDS; CCDS6937.1; -. [Q8N539-1]
DR   RefSeq; NP_001138578.1; NM_001145106.1. [Q8N539-1]
DR   RefSeq; NP_116232.3; NM_032843.4. [Q8N539-1]
DR   PDB; 4M7F; X-ray; 2.10 A; A/B=236-461.
DR   PDB; 4M7H; X-ray; 2.00 A; A/B=236-461.
DR   PDB; 6ZQR; X-ray; 1.93 A; A/B=236-461.
DR   PDB; 6ZQX; X-ray; 1.84 A; A/B=236-461.
DR   PDB; 6ZQY; X-ray; 1.85 A; A/B=236-461.
DR   PDB; 6ZR0; X-ray; 1.94 A; A/B=236-461.
DR   PDB; 6ZR3; X-ray; 1.97 A; A/B=236-461.
DR   PDB; 6ZR4; X-ray; 2.00 A; A/B=236-461.
DR   PDBsum; 4M7F; -.
DR   PDBsum; 4M7H; -.
DR   PDBsum; 6ZQR; -.
DR   PDBsum; 6ZQX; -.
DR   PDBsum; 6ZQY; -.
DR   PDBsum; 6ZR0; -.
DR   PDBsum; 6ZR3; -.
DR   PDBsum; 6ZR4; -.
DR   AlphaFoldDB; Q8N539; -.
DR   SMR; Q8N539; -.
DR   BioGRID; 124363; 15.
DR   IntAct; Q8N539; 1.
DR   STRING; 9606.ENSP00000361413; -.
DR   ChEMBL; CHEMBL4523397; -.
DR   UniLectin; Q8N539; -.
DR   GlyGen; Q8N539; 1 site.
DR   iPTMnet; Q8N539; -.
DR   PhosphoSitePlus; Q8N539; -.
DR   BioMuta; FIBCD1; -.
DR   DMDM; 152032456; -.
DR   MassIVE; Q8N539; -.
DR   PaxDb; Q8N539; -.
DR   PeptideAtlas; Q8N539; -.
DR   PRIDE; Q8N539; -.
DR   ProteomicsDB; 71998; -. [Q8N539-1]
DR   Antibodypedia; 31542; 80 antibodies from 17 providers.
DR   DNASU; 84929; -.
DR   Ensembl; ENST00000372338.9; ENSP00000361413.4; ENSG00000130720.13. [Q8N539-1]
DR   Ensembl; ENST00000448616.5; ENSP00000414501.1; ENSG00000130720.13. [Q8N539-1]
DR   GeneID; 84929; -.
DR   KEGG; hsa:84929; -.
DR   MANE-Select; ENST00000372338.9; ENSP00000361413.4; NM_032843.5; NP_116232.3.
DR   UCSC; uc004bzz.4; human. [Q8N539-1]
DR   CTD; 84929; -.
DR   DisGeNET; 84929; -.
DR   GeneCards; FIBCD1; -.
DR   HGNC; HGNC:25922; FIBCD1.
DR   HPA; ENSG00000130720; Group enriched (adrenal gland, brain, parathyroid gland, testis).
DR   MIM; 613357; gene.
DR   neXtProt; NX_Q8N539; -.
DR   OpenTargets; ENSG00000130720; -.
DR   PharmGKB; PA134891641; -.
DR   VEuPathDB; HostDB:ENSG00000130720; -.
DR   eggNOG; KOG2579; Eukaryota.
DR   GeneTree; ENSGT00940000155976; -.
DR   HOGENOM; CLU_038628_5_1_1; -.
DR   InParanoid; Q8N539; -.
DR   OMA; PQRMSCG; -.
DR   OrthoDB; 523014at2759; -.
DR   PhylomeDB; Q8N539; -.
DR   TreeFam; TF351983; -.
DR   PathwayCommons; Q8N539; -.
DR   SignaLink; Q8N539; -.
DR   BioGRID-ORCS; 84929; 35 hits in 1066 CRISPR screens.
DR   ChiTaRS; FIBCD1; human.
DR   GenomeRNAi; 84929; -.
DR   Pharos; Q8N539; Tbio.
DR   PRO; PR:Q8N539; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q8N539; protein.
DR   Bgee; ENSG00000130720; Expressed in right adrenal gland cortex and 142 other tissues.
DR   ExpressionAtlas; Q8N539; baseline and differential.
DR   Genevisible; Q8N539; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0008061; F:chitin binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central.
DR   GO; GO:0007155; P:cell adhesion; IBA:GO_Central.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 3.90.215.10; -; 1.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR014716; Fibrinogen_a/b/g_C_1.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR020837; Fibrinogen_CS.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   SMART; SM00186; FBG; 1.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS00514; FIBRINOGEN_C_1; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Chitin-binding;
KW   Disulfide bond; Glycoprotein; Membrane; Metal-binding; Reference proteome;
KW   Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN           1..461
FT                   /note="Fibrinogen C domain-containing protein 1"
FT                   /id="PRO_0000294315"
FT   TOPO_DOM        1..33
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        34..54
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        55..461
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          235..458
FT                   /note="Fibrinogen C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   REGION          1..24
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          214..238
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         393
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         395
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   SITE            405
FT                   /note="Implicated in ligand binding"
FT   SITE            415
FT                   /note="Implicated in ligand binding"
FT   SITE            431
FT                   /note="Implicated in ligand binding"
FT   SITE            432
FT                   /note="Implicated in ligand binding"
FT   CARBOHYD        340
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        244..273
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   DISULFID        401..414
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   VAR_SEQ         1..158
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_026618"
FT   VAR_SEQ         317..357
FT                   /note="LKRIHALTTQAAYELHVDLEDFENGTAYARYGSFGVGLFSV -> PLDRCTL
FT                   SLALLVPVAPSPTPPHSFVNVLHPPVPGGPTLQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_026619"
FT   VAR_SEQ         358..461
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_026620"
FT   MUTAGEN         393
FT                   /note="D->N: Complete loss of binding to acetylated bovine
FT                   serum albumin and reduced binding to chitin; when
FT                   associated with A-395."
FT                   /evidence="ECO:0000269|PubMed:19892701"
FT   MUTAGEN         395
FT                   /note="D->A: Complete loss of binding to acetylated bovine
FT                   serum albumin and reduced binding to chitin; when
FT                   associated with N-395."
FT                   /evidence="ECO:0000269|PubMed:19892701"
FT   MUTAGEN         405
FT                   /note="Y->S: Significantly reduced binding to acetylated
FT                   bovine serum albumin and loss of binding to chitin; when
FT                   associated with S-431."
FT                   /evidence="ECO:0000269|PubMed:19892701"
FT   MUTAGEN         415
FT                   /note="H->G: Complete loss of binding to acetylated bovine
FT                   serum albumin and chitin."
FT                   /evidence="ECO:0000269|PubMed:19892701"
FT   MUTAGEN         431
FT                   /note="Y->S: Significantly reduced binding to acetylated
FT                   bovine serum albumin and loss of binding to chitin; when
FT                   associated with S-405."
FT                   /evidence="ECO:0000269|PubMed:19892701"
FT   MUTAGEN         432
FT                   /note="A->V: Complete loss of binding to acetylated bovine
FT                   serum albumin and chitin."
FT                   /evidence="ECO:0000269|PubMed:19892701"
FT   MUTAGEN         443
FT                   /note="W->S: Slight reduction in binding to acetylated
FT                   bovine serum albumin and no effect on binding to chitin."
FT                   /evidence="ECO:0000269|PubMed:19892701"
FT   CONFLICT        79
FT                   /note="L -> V (in Ref. 4; AAH32953)"
FT                   /evidence="ECO:0000305"
FT   HELIX           244..249
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   STRAND          256..260
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   STRAND          269..274
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   HELIX           277..279
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   STRAND          282..291
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   HELIX           299..304
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   STRAND          311..314
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   HELIX           317..324
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   STRAND          329..336
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   STRAND          342..353
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   TURN            359..363
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   STRAND          366..375
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   HELIX           380..382
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   STRAND          395..399
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   HELIX           401..404
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   STRAND          412..414
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   STRAND          416..418
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   STRAND          429..432
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   STRAND          434..437
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   HELIX           438..441
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   STRAND          443..446
FT                   /evidence="ECO:0007829|PDB:6ZQX"
FT   STRAND          448..456
FT                   /evidence="ECO:0007829|PDB:6ZQX"
SQ   SEQUENCE   461 AA;  50744 MW;  B217DBFD370A3443 CRC64;
     MVNDRWKTMG GAAQLEDRPR DKPQRPSCGY VLCTVLLALA VLLAVAVTGA VLFLNHAHAP
     GTAPPPVVST GAASANSALV TVERADSSHL SILIDPRCPD LTDSFARLES AQASVLQALT
     EHQAQPRLVG DQEQELLDTL ADQLPRLLAR ASELQTECMG LRKGHGTLGQ GLSALQSEQG
     RLIQLLSESQ GHMAHLVNSV SDILDALQRD RGLGRPRNKA DLQRAPARGT RPRGCATGSR
     PRDCLDVLLS GQQDDGVYSV FPTHYPAGFQ VYCDMRTDGG GWTVFQRRED GSVNFFRGWD
     AYRDGFGRLT GEHWLGLKRI HALTTQAAYE LHVDLEDFEN GTAYARYGSF GVGLFSVDPE
     EDGYPLTVAD YSGTAGDSLL KHSGMRFTTK DRDSDHSENN CAAFYRGAWW YRNCHTSNLN
     GQYLRGAHAS YADGVEWSSW TGWQYSLKFS EMKIRPVRED R
//
